drugset / Trial / NCT03067597
An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term
NaSingle-groupOpen-labelTreatment
Summary
To demonstrate the efficacy of controlled-release dinoprostone vaginal insert (DVI) for cervical ripening success (either Bishop Score (BS) ≥7 or vaginal delivery) within 12 hours of vaginal insert administration.
Timeline
- Start
- 2017-02-22
- Primary completion
- 2018-02-24
- Completion
- 2018-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 10 mg | Other |